Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 82
Central Nervous System Drugs 67
Endocrine and Metabolic Disorders Drugs 50
Infusions and Injectables 33
Musculoskeletal Disorders Drugs 27
Surgical Procedures 21
Drug Discovery 20
Pharmaceuticals 20
Biopharmaceuticals 15
Prostate Cancer Drugs 13
Drug Delivery 13
Liver Cancer Drugs 10
Women's Health 10
Clinical Trials 10
Dermatology 10
Oncology 10
Neurology 9
Pancreatic Cancer Drugs 9
Medical Devices 8
Thyroid Cancer Drugs 8
Biotechnology 7
Lung Cancer Drugs 7
Healthcare Services 6
Breast Cancer Drugs 6
Genomics 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Company Reports 5
Immune Disorders Drugs 5
Kidney Cancer Drugs 5
Dermatological Drugs 5
Urology and Nephrology 4
Brain Cancer Drugs 4
Enzymes 4
Sexual and Reproductive Health Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Ovarian Cancer Drugs 3
Colon Cancer Drugs 3
Bladder Cancer Drugs 3
Managed Care 3
Over the Counter (OTC) Drugs 3
Urological Disorders Drugs 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Needles and Syringes 2
Hematology 2
Surgical Devices 2
Hematological Drugs 2
Biosimilars and Biosuperiors 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Healthcare 1
Transdermal and Transmucosal Drug Delivery 1
Nuclear Medicine and Radiopharmacology 1
Skin Cancer Drugs 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Endocrinology 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

452 Results (Page 12 of 23)
- Relevance
  Sort by

France Healthcare Outlook Report, 2022

 Report
January 2022
60 Pages
France

From

€1421EUR$1,596USD£1,241GBP

€1776EUR$1,995USD£1,552GBP

Gallbladder Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1068EUR$1,200USD£933GBP

€1335EUR$1,500USD£1,167GBP

Tie-2 Modulators - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1068EUR$1,200USD£933GBP

€1335EUR$1,500USD£1,167GBP

Growth Hormone Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€890EUR$1,000USD£778GBP

€1113EUR$1,250USD£972GBP

Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
507 Pages
Global

From

€2226EUR$2,500USD£1,945GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pancreatic Cancer Treatment - Global Strategic Business Report

 Report
October 2025
381 Pages
Global

From

€5208EUR$5,850USD£4,550GBP

Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€890EUR$1,000USD£778GBP

€1113EUR$1,250USD£972GBP

Botulinum Toxin Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
117 Pages
Global

From

€4006EUR$4,500USD£3,500GBP

D1 Agonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€890EUR$1,000USD£778GBP

€1113EUR$1,250USD£972GBP

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1588 Pages
Global

From

€2226EUR$2,500USD£1,945GBP

Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
746 Pages
Global

From

€2226EUR$2,500USD£1,945GBP

Global Biosimilars Partnering Terms and Agreements 2010 to 2023

 Report
June 2023
150 Pages
Global

From

€3556EUR$3,995USD£3,107GBP

Botulinum Toxin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

 Report
January 2025
99 Pages
Global

From

€3500EUR$4,212USD£3,165GBP

Recombinant Hormone Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

 Report
April 2023
115 Pages
Global

From

€4228EUR$4,750USD£3,695GBP

OTC Consumer Health Products Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
November 2023
118 Pages
Global

From

€3500EUR$4,212USD£3,165GBP

Polycystic Kidney Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
August 2023
172 Pages
Global

From

€2226EUR$2,500USD£1,945GBP

Oligodendroglioma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
September 2024
96 Pages
Global

From

€3500EUR$4,212USD£3,165GBP

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Asia Edition - The Views of 300 Asian Patient Groups

 Report
August 2022
58 Pages
Asia Pacific

€9476EUR$11,017USD£8,000GBP

Adrenocortical Carcinoma- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€890EUR$1,000USD£778GBP

€1113EUR$1,250USD£972GBP

Pituitary ACTH Hypersecretion Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
96 Pages
Global

From

€3500EUR$4,212USD£3,165GBP

452 Results (Page 12 of 23)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.